Drug intelligence / Profile preview

guanxin suhe capsules

Development stage: Unknown
Lead developer: Tianjin Hong Ren Tang Pharmaceutical
Administration: Oral

Overview

Guanxin Suhe Capsules is a traditional Chinese medicine (TCM) product developed and manufactured by Tianjin Hong Ren Tang Pharmaceutical. It is primarily indicated for the treatment of coronary heart disease and angina pectoris. The formulation is based on a classic aromatic TCM recipe designed to warm the heart, regulate qi, and alleviate pain. It typically consists of five key ingredients: Styrax (Suhexiang), Borneol (Bingpian), Sandalwood (Tanxiang), Dalbergia wood (Jiangxiang), and Frankincense (Ruxiang). Pharmacologically, the capsules act by dilating coronary arteries, increasing coronary blood flow, and reducing myocardial oxygen consumption. It also exhibits anti-platelet aggregation properties, which help prevent thrombus formation. Clinically, it is used to relieve chest pain and pressure associated with cold stagnation and qi obstruction in the chest.

Brand names: Guanxin Suhe Capsules冠心苏合胶囊
Other names: Guanxin Suhe Jiaonang

Targets

CCL2 (C-C motif chemokine 2)NOS2 (Nitric Oxide Synthase 2)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL-6 (Interleukin 6)CASP3 (Caspase-3)JUN (Transcription factor Jun)MMP9 (Matrix metalloproteinase-9)RELA (Nuclear Factor Kappa B Subunit p65)EGFR T790M (Epidermal growth factor receptor T790M mutant)VEGFA (Vascular endothelial growth factor A)TP53 (Cellular Tumor Antigen p53 R175H)STAT3 (Signal Transducer and Activator of Transcription 3)MAPK14 (p38 mitogen-activated protein kinase alpha)IL8 (C-X-C Motif Chemokine Ligand 8)IL10 (Interleukin-10)

Beyond the preview

Go deeper on guanxin suhe capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on guanxin suhe capsules.

Explore the full profile